share_log

Morgan Stanley Maintains Equal-Weight on C4 Therapeutics, Raises Price Target to $8

Morgan Stanley Maintains Equal-Weight on C4 Therapeutics, Raises Price Target to $8

摩根士丹利对C4 Therapeutics保持同等权重,将目标股价上调至8美元
Moomoo 24/7 ·  02/26 10:42

Morgan Stanley analyst Terence Flynn maintains C4 Therapeutics (NASDAQ:CCCC) with a Equal-Weight and raises the price target from $1 to $8.

摩根士丹利分析师特伦斯·弗林维持C4 Therapeutics(纳斯达克股票代码:CCCC)的权重相等,并将目标股价从1美元上调至8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发